Home Newsfeeds Barclays Maintains Overweight on Allegro Microsystems, Lowers Price Target to $26

Barclays Maintains Overweight on Allegro Microsystems, Lowers Price Target to $26

Barclays analyst Blayne Curtis maintains Allegro Microsystems (NASDAQ:ALGM) with a Overweight and lowers the price target from $31 to $26.

byBenzinga Newsdesk

July 25, 2022

1 minute read

Barclays analyst Blayne Curtis maintains Allegro Microsystems (NASDAQ:ALGM) with a Overweight and lowers the price target from $31 to $26.

Leaked Email Shows Elon Musk Calling For High Standard Of Quality In Cybertruck Production: ‘If Lego And Soda Cans Do It, So Can We’

By Benzinga Neuro

August 23, 11:41 PM

According to a leaked email, Elon Musk CEO of Tesla Inc. (NASDAQ:TSLA), has set “single-digit micron” tolerance as the standard for the…

TSLA

FDA Advisory Committee Votes Favoring Pfizer’s COVID-19 Pill Paxlovid

By Vandana Singh

March 17, 9:04 AM

The FDA’s Antimicrobial Drugs Advisory Committee voted 16-1 that available data support the safety and effectiveness of Pfizer Inc’s (NYSE:PFE) Paxlovid for…

PFE

Onyx Suffers Breach As Attacker Swaps ETH For PEPE, ‘Precision Loss’ Of Over $2M

By Murtuza Merchant

Yesterday, 10:35 AM

Decentralized finance (DeFi) protocol Onyx recently experienced a significant security breach that resulted in the misappropriation of about $2.1 million.

ETH

Tupperware Stock Is Exploding Higher: What’s Going On?

By Adam Eckert

August 3, 5:18 PM

Tupperware Brands Corp (NYSE: TUP) shares are trading higher in Thursday's after-hours session after the company announced a debt restructuring agreement.

TUP

Barclays Maintains Overweight on Allegro Microsystems, Lowers Price Target to $26

Related Posts

Leaked Email Shows Elon Musk Calling For High Standard Of Quality In Cybertruck Production: ‘If Lego And Soda Cans Do It, So Can We’

FDA Advisory Committee Votes Favoring Pfizer’s COVID-19 Pill Paxlovid

Onyx Suffers Breach As Attacker Swaps ETH For PEPE, ‘Precision Loss’ Of Over $2M

Tupperware Stock Is Exploding Higher: What’s Going On?